Skip to main content
UTI
NYSE Trade & Services

Universal Technical Institute Reports Q1 Fiscal 2026 Results with Profit Decline Amid Strategic Growth Investments

Analysis by Wiseek AI
Sentiment info
Negative
Importance info
7
Price
$27.86
Mkt Cap
$1.533B
52W Low
$21.29
52W High
$36.32
Market data snapshot near publication time

Summary

Universal Technical Institute reported a 42% drop in Q1 net income and negative free cash flow due to strategic growth investments, despite revenue and student growth, while reiterating full-year guidance.


Key Events

  • Q1 Fiscal 2026 Revenue Growth

    Revenue increased 9.6% year-over-year to $220.8 million.

  • Significant Profitability Decline

    Net income fell 42.1% to $12.8 million, with diluted EPS at $0.23, primarily due to strategic growth expenses.

  • Adjusted EBITDA Impacted by Investments

    Adjusted EBITDA decreased 23.5% to $27.1 million, reflecting $7.6 million in strategic growth investments.

  • Operational Growth Continues

    Average full-time active students grew 7.2% to 26,858, and new student starts increased 2.6%.


Analysis

Universal Technical Institute Inc. reported a significant decline in first-quarter fiscal 2026 net income and adjusted EBITDA, primarily due to substantial strategic growth expenses and investments in new campuses and program expansions. While revenue and student enrollment showed positive growth, the increased operating expenses led to a sharp drop in profitability and negative adjusted free cash flow for the quarter. The company, however, reiterated its full-year fiscal 2026 guidance, indicating these results were in line with its "North Star strategy" for long-term growth and diversification. Investors will need to weigh the short-term impact of these investments on profitability against the potential for future growth and shareholder value creation.

At the time of this filing, UTI was trading at $27.86 on NYSE in the Trade & Services sector, with a market capitalization of approximately $1.5B. The 52-week trading range was $21.29 to $36.32. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

UTI - Latest Insights

UTI
Jun 10, 2026, 5:59 PM EDT
Filing Type: 4
Importance Score:
9
Price at Filing: $39.55
Real-time Price: $39.14 info
Change: -$0.410 (-1%) info
Market Cap: $2.155B info
UTI
Jun 10, 2026, 5:52 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
8
Price at Filing: $39.55
Real-time Price: $39.14 info
Change: -$0.410 (-1%) info
Market Cap: $2.155B info
UTI
Jun 08, 2026, 6:42 PM EDT
Filing Type: 144
Importance Score:
9
Price at Filing: $41.00
Real-time Price: $39.14 info
Change: -$1.86 (-5%) info
Market Cap: $2.155B info
UTI
May 07, 2026, 8:59 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $35.65
Real-time Price: $39.14 info
Change: +$3.49 (+10%) info
Market Cap: $2.155B info
UTI
May 06, 2026, 4:26 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $35.27
Real-time Price: $39.14 info
Change: +$3.87 (+11%) info
Market Cap: $2.155B info
UTI
May 06, 2026, 4:04 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $35.50
Real-time Price: $39.14 info
Change: +$3.64 (+10%) info
Market Cap: $2.155B info
UTI
Mar 06, 2026, 6:00 PM EST
Filing Type: 4
Importance Score:
7
Price at Filing: $34.99
Real-time Price: $39.14 info
Change: +$4.15 (+12%) info
Market Cap: $2.155B info
UTI
Mar 04, 2026, 8:16 PM EST
Filing Type: 4
Importance Score:
7
Price at Filing: $35.82
Real-time Price: $39.14 info
Change: +$3.32 (+9%) info
Market Cap: $2.155B info
UTI
Mar 02, 2026, 7:45 PM EST
Filing Type: 4
Importance Score:
7
Price at Filing: $37.40
Real-time Price: $39.14 info
Change: +$1.74 (+5%) info
Market Cap: $2.155B info
UTI
Feb 04, 2026, 4:04 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $27.86
Real-time Price: $39.14 info
Change: +$11.28 (+40%) info
Market Cap: $2.155B info